Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients. The gene discussed is HRAS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.